News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,823 Results
Type
Article (14195)
Company Profile (282)
Press Release (252346)
Section
Business (79625)
Career Advice (153)
Deals (13244)
Drug Delivery (35)
Drug Development (50442)
Employer Resources (31)
FDA (5739)
Job Trends (5134)
News (144578)
Policy (10055)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21643)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5754)
Artificial intelligence (108)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4566)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1288)
Cardiovascular disease (105)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (305)
Cervical cancer (8)
Clinical research (40870)
Collaboration (497)
Compensation (218)
Complete response letters (13)
COVID-19 (1035)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1346)
Denatured (11)
Depression (28)
Diabetes (125)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29716)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48156)
Executive appointments (396)
FDA (6357)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (463)
Gene editing (87)
Generative AI (9)
Gene therapy (228)
GLP-1 (353)
Government (1077)
Grass and pollen (2)
Guidances (18)
Healthcare (6591)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (79)
Indications (18)
Infectious disease (1097)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1408)
Liver cancer (30)
Lung cancer (185)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (115)
MASH (48)
Medical device (2594)
Medtech (2595)
Mergers & acquisitions (6269)
Metabolic disorders (363)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1188)
NextGen: Class of 2025 (2018)
Non-profit (852)
Northern California (1535)
Now hiring (21)
Obesity (185)
Opinion (100)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (8)
Patents (109)
Patient recruitment (66)
Peanut (35)
People (25523)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14428)
Phase II (19016)
Phase III (12022)
Pipeline (687)
Podcasts (46)
Policy (36)
Postmarket research (852)
Preclinical (6060)
Press Release (30)
Prostate cancer (53)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (272)
Real estate (1416)
Recruiting (12)
Regulatory (8558)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (3)
RSV (10)
Schizophrenia (55)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1359)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1972)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (12004)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (61)
Last 7 days (388)
Last 30 days (1504)
Last 365 days (19996)
2025 (4619)
2024 (20554)
2023 (22417)
2022 (26842)
2021 (27823)
2020 (23370)
2019 (16241)
2018 (11749)
2017 (13760)
2016 (11861)
2015 (14376)
2014 (10419)
2013 (7506)
2012 (7567)
2011 (7647)
2010 (7455)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17352)
Australia (2916)
California (3489)
Canada (1046)
China (321)
Colorado (135)
Connecticut (143)
Delaware (87)
Europe (37023)
Florida (408)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (69)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (442)
Massachusetts (2747)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (874)
New Mexico (12)
New York (949)
North Carolina (516)
North Dakota (4)
Northern California (1535)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (669)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1359)
Tennessee (25)
Texas (400)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (317)
Wisconsin (13)
266,823 Results for "candel therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Prostate cancer
Candel Stock Skyrockets on Promising Phase III Prostate Cancer Data
Candel’s trial was conducted under the FDA’s Special Protocol Assessment program, meaning that its data could be used as a basis for a regulatory application.
December 12, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
March 14, 2025
·
17 min read
Press Releases
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
March 20, 2025
·
9 min read
Press Releases
Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board
March 19, 2025
·
5 min read
Press Releases
Candel Therapeutics Announces Pricing of Public Offering
December 13, 2024
·
5 min read
Genetown
Candel Therapeutics to Present at the 2024 Jefferies Global Healthcare Conference
Candel Therapeutics, Inc. announced that Paul Peter Tak, MD, PhD, FMedSci, Candel’s President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 5:30 p.m. ET.
May 22, 2024
·
4 min read
Press Releases
Candel Therapeutics Announces $80 Million Proposed Public Offering
December 13, 2024
·
5 min read
Genetown
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL) today announced that Paul Peter Tak, MD, PhD, FMedSci, Candel’s President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024 at 3:00 p.m. ET.
June 18, 2024
·
5 min read
Press Releases
Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
February 26, 2025
·
10 min read
Press Releases
Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025
January 13, 2025
·
16 min read
1 of 26,683
Next
